Literature DB >> 21107550

The treatment of a dural carotid cavernous fistula (CCF) using Onyx via a transorbital approach: a technical note.

Homoyoon Mehrzad1, Kushnood Alam, Adam Rennie.   

Abstract

We report the successful case of embolisation of a Barrow D (White et al. in Am J Neuroradiol 28:1415-1417, 2007) dural carotid cavernous fistula (CCF) with bilateral external carotid artery and internal carotid arterial supply, using a direct percutaneous transorbital approach with the embolic agent Onyx. In particular, we highlight the properties of Onyx which make it suitable to treat the multi-compartmental nature of CCFs. The patient developed transient complications which may be related to the volume of embolic agent used, and we discuss this point further. This is still a developing technique, and we present our case as a technical note to aid those contemplating embolisation via a transorbital approach with Onyx.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21107550     DOI： 10.1007/s00234-010-0799-x

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  6 in total

1.  Direct-puncture approach to the extraconal portion of the superior ophthalmic vein for carotid cavernous fistulae.

Authors:  A Kurata; S Suzuki; K Iwamoto; T Miyazaki; M Inukai; K Abe; J Niki; M Yamada; K Fujii; S Kan
Journal:  Neuroradiology       Date:  2009-07-04       Impact factor: 2.804

2.  Onyx embolization of carotid-cavernous fistulas.

Authors:  Mohamed Samy Elhammady; Stacey Quintero Wolfe; Hamad Farhat; Roham Moftakhar; Mohammad Ali Aziz-Sultan
Journal:  J Neurosurg       Date:  2010-03       Impact factor: 5.115

3.  Onyx embolisation of cavernous sinus dural arteriovenous fistula via direct percutaneous transorbital puncture.

Authors:  C K Ong; L L Wang; R J Parkinson; J D Wenderoth
Journal:  J Med Imaging Radiat Oncol       Date:  2009-06       Impact factor: 1.735

4.  Successful transarterial embolization of a Barrow type D dural carotid-cavernous fistula with ethylene vinyl alcohol copolymer (Onyx).

Authors:  Dheeraj Gandhi; Sameer A Ansari; Wayne T Cornblath
Journal:  J Neuroophthalmol       Date:  2009-03       Impact factor: 3.042

5.  Successful treatment of six cases of indirect carotid-cavernous fistula with ethylene vinyl alcohol copolymer (Onyx) transvenous embolization.

Authors:  Kartik D Bhatia; Lily Wang; Richard J Parkinson; Jason D Wenderoth
Journal:  J Neuroophthalmol       Date:  2009-03       Impact factor: 3.042

6.  Transorbital puncture for the treatment of cavernous sinus dural arteriovenous fistulas.

Authors:  J B White; K F Layton; A J Evans; F C Tong; M E Jensen; D F Kallmes; J E Dion; H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825
  6 in total
  4 in total

1.  Onyx embolization of dural arteriovenous fistulas of the cavernous sinus through the superior pharyngeal branch of the ascending pharyngeal artery.

Authors:  Guglielmo Pero; Luca Quilici; Mariangela Piano; Luca Valvassori; Edoardo Boccardi
Journal:  BMJ Case Rep       Date:  2014-04-23

Review 2.  The working road map in a neurosurgical Hybrid Angio-Surgical suite------ development and practice of a neurosurgical Hybrid Angio-Surgical suite.

Authors:  Zeguang Ren; Shuo Wang; Kaya Xu; Maxim Mokin; Yuanli Zhao; Yong Cao; Jia Wang; Hancheng Qiu; Siviero Agazzi; Harry van Loveren; Jizong Zhao
Journal:  Chin Neurosurg J       Date:  2018-03-22

3.  Neuro-Endovascular Intervention in Traumatic Carotico-Cavernous Fistulae: A Single-Center Experience.

Authors:  Muhamad Thohar Arifin; Mohammad Ali Akbar; Widianto Illyasa; Krisna Tsaniadi Prihastomo
Journal:  Int J Gen Med       Date:  2020-10-21

4.  Transorbital Approach for Endovascular Occlusion of Carotid-Cavernous Fistulas: Technical Note and Review of the Literature.

Authors:  Ching-Jen Chen; Panagiotis Mastorakos; James P Caruso; Dale Ding; Paul J Schmitt; Thomas J Buell; Daniel M Raper; Avery Evans; Steven A Newman; Mary E Jensen
Journal:  Cureus       Date:  2017-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.